Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

EPA/BLC stock hub

EPA/BLC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

EPA/BLCis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
197.9M
Euronext Paris
Market data

Price

Recent price action with selectable time range.

EPA/BLCEPA/BLC
—
Loading chart…
In the news

Latest news · EPA/BLC

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.4
P25 n/aP50 n/aP75 n/a
Trailing P/E22.1
P25 n/aP50 n/aP75 n/a
ROE11.6
P25 n/aP50 n/aP75 n/a
ROIC8.6
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All EPA/BLC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
234
Groups with data
11
Currency
EUR
Showing 234 of 234 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
France
Country code
FR
Employees
3,641
Employees Change
6%
Employees Change Percent
0.17
Enterprise value
EUR 496.3M
Exchange
Euronext Paris
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Distribution
Isin
FR0000035370
Last refreshed
2026-05-10
Market cap
EUR 197.9M
Price
EUR 26.7
Price currency
EUR
Rev Per Employee
140,198.57x
Sector
Healthcare
Sic
7350
Symbol
epa/BLC
Website
https://www.bastideleconfortmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
14.89%
EV Earnings
16.84x
EV/EBIT
10.38x
EV/EBITDA
4.66x
EV/FCF
8.95x
EV/Sales
0.97x
FCF yield
28.02%
Forward P/E
11.36x
P/B ratio
1.93x
P/E ratio
22.09x
P/S ratio
0.39x
PE Ratio10 Y
76.37x
PE Ratio3 Y
187.14x
PE Ratio5 Y
134.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
9.36%
EBITDA Margin
16.96%
FCF margin
10.86%
Gross margin
67.39%
Gross Profit
EUR 344M
Gross Profit Growth
3.3%
Gross Profit Growth Q
6.67%
Gross Profit Growth3 Y
3.68%
Gross Profit Growth5 Y
0.61%
Net Income
EUR 29.5M
Net Income Growth
1,652.26%
Net Income Growth Q
4,914.26%
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Net Income Growth5 Y
19.59%
Pretax Margin
2.81%
Profit Margin
5.77%
Profit Per Employee
EUR 8,095
Profitable Years
1
ROA
4.75
Roa5y
4.11
ROCE
11.58
ROE
11.56
Roe5y
13.45
ROIC
8.64
Roic5y
5.53

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

27
MetricValue
Cagr10y
3.87%
Cagr15y
8.39%
Cagr1y
-1.48%
Cagr20y
4.96%
Cagr3y
-1.98%
Cagr5y
-10.03%
Div CAGR10
0.38%
Div CAGR5
0%
EPS Growth
1,576.9
EPS Growth Q
4,611.9
EPS Growth Quarters
1
EPS Growth Years
1
EPS Growth5 Y
18.87
FCF Growth
62.24%
FCF Growth Q
76.03%
FCF Growth3 Y
31.37%
FCF Growth5 Y
1.28%
OCF Growth
31.7%
OCF Growth Q
25.19%
OCF Growth10 Y
9.15%
OCF Growth3 Y
15.39%
OCF Growth5 Y
1.45%
Revenue Growth
16.56x
Revenue Growth Q
8x
Revenue Growth Years
0x
Revenue Growth3 Y
3.39x
Revenue Growth5 Y
0.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 0.81
Assets
EUR 580.5M
Cash
EUR 25.5M
Current Assets
EUR 194.1M
Current Liabilities
EUR 168M
Debt
EUR 324.1M
Debt EBITDA
EUR 3.04
Debt Equity
EUR 3.16
Debt FCF
EUR 5.84
Equity
EUR 102.4M
Interest Coverage
1.75
Liabilities
EUR 478.1M
Long Term Assets
EUR 386.4M
Long Term Liabilities
EUR 310.1M
Net Cash
EUR -298.7M
Net Cash By Market Cap
EUR -151
Net Debt EBITDA
EUR 3.45
Net Debt Equity
EUR 2.92
Net Debt FCF
EUR 5.39
Tangible Book Value
EUR -89.8M
Tangible Book Value Per Share
EUR -12.12
WACC
7.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.16
Inventory Turnover
3.95
Net Working Capital
EUR 22.2M
Quick ratio
0.9
Working Capital
EUR 26.1M
Working Capital Turnover
EUR 16.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-2.95%
Dividend per share
EUR 0
Last Dividend
EUR 0.27

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
46.17%
1Y total return
-1.48%
200-day SMA
25.17
3Y total return
-5.82%
50-day SMA
24.87
50-day SMA vs 200-day SMA
50under200
5Y total return
-41.05%
All Time High
61.4
All Time High Change
-56.51%
All Time High Date
2018-01-05
All Time Low
1.92
All Time Low Change
1,289.9%
All Time Low Date
2003-03-07
ATR
0.65
Beta
0.89
Beta1y
1.1
Beta2y
0.85
Ch YTD
11.25
High
26.85
High52
33.3
High52 Date
2025-07-11
High52ch
-19.82%
Low
26.55
Low52
21.95
Low52 Date
2026-02-06
Low52ch
21.64%
Ma50ch
7.36%
Price vs 200-day SMA
6.08%
RSI
63.76
RSI Monthly
52.14
RSI Weekly
55.73
Sharpe ratio
0.01x
Sortino ratio
0.19
Total Return
-2.95%
Tr YTD
11.25
Tr15y
234.97%
Tr1m
5.95%
Tr1w
-0.56%
Tr3m
21.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 47.8M
Operating Income Growth
5.71
Operating Income Growth Q
10.89
Operating Income Growth3 Y
7.44
Operating Income Growth5 Y
2.21
Operating margin
9.36

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
3,394,508%
Net Borrowing
-103,019,000
Shares Insiders
1.62%
Shares Institutions
7.07%
Shares Out
7,412,167
Shares Qo Q
0.11%
Shares Yo Y
2.95%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
EUR 55.5M
Average Volume
2,729.75x
Bv Per Share
13.86
CAPEX
EUR -58.1M
Ch10y
41.2
Ch15y
196.7
Ch1m
5.95
Ch1w
-0.56
Ch1y
-1.48
Ch20y
123.7
Ch3m
21.36
Ch3y
-5.82
Ch5y
-41.38
Ch6m
9.88
Change
0.38%
Change From Open
0.38
Close
26.6
Days Gap
0
Depreciation Amortization
38,796,000
Dollar Volume
51,290.7
Earnings Date
2026-10-21
EBIT
EUR 47.8M
EBITDA
EUR 86.6M
EPS
EUR 3.61
F Score
6
FCF
EUR 55.5M
FCF EV Yield
11.17x
FCF Per Share
EUR 7.48
Financing CF
-130,092,000
Fiscal Year End
June
Founded
1,976
Goodwill
182,025,000
Graham Number
33.5425
Graham Upside
25.63
Income Tax
EUR 3.9M
Investing CF
20,246,000
Is Primary Listing
1
Last Earnings Date
2026-03-18
Last Report Date
2025-12-31
Last Split Date
2007-12-19
Last Split Type
Forward
Lynch Fair Value
EUR 70.68
Lynch Upside
164.7
Ma150
24.62
Ma150ch
8.44%
Ma20
25.64
Ma20ch
4.13%
Net CF
3,568,000
Next Earnings Date
2026-10-21
Open
26.6
P FCF Ratio
3.57
P OCF Ratio
1.74
Position In Range
50
Ppne
185,010,000
Price Date
2026-05-08
Price EBITDA
EUR 2.29
Relative Volume
0.72x
Revenue
510,463,000x
Tax By Revenue
0.77x
Tax Rate
27.48%
Tr20y
163.11%
Tr6m
9.88%
Volume
1,921
Z Score
1.67
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does EPA/BLC pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/BLC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-1.5%
S&P 500 1Y: n/a
3Y total return
-5.8%
S&P 500 3Y: n/a
5Y total return
-41.1%
S&P 500 5Y: n/a
10Y total return
+46.2%
S&P 500 10Y: n/a
Ownership

Who owns EPA/BLC?

Insider, institutional, and short-interest positioning.

Institutional ownership
+7.1%
Share of float held by funds and institutions
Insider ownership
+1.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+2.9%
Negative means the company is buying back shares.
Technical

EPA/BLC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
63.8
Neutral momentum band
Price vs 200-day MA
+6.1%
50/200-day relationship not available
Beta (5Y)
0.89
Moves roughly with the market
Sharpe ratio
0.01
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About EPA/BLC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/BLC stock rating?

epa/BLC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/BLC analysis?

The full report lives at /stocks/epa/BLC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/BLC?

The latest report frames epa/BLC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/BLC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.